The registration, importation and distribution of all heartburn medication containing ranitidine has been suspended in the UAE.
According to the Ministry of Health and Prevention (MoHAP), a circular was issued to health facilities and practitioners informing them about the move.
The decision is based on the recommendations of the US Food and Drug Administration (FDA) and other regulatory bodies regarding a possible contamination of the medicine with an impurity which is classified as potentially carcinogenic.
The Ministry says those wishing to stop taking medicine with ranitidine should consult a healthcare professional for a replacement.

UAE President to begin state visit to Germany on Wednesday
Sheikh Mansour approves family charter to protect children after divorce
H.H. Sheikh Mohammed hails Dubai Crown Prince as 'pillar' of his journey
UAE flights to Jakarta face disruptions due to volcanic ash
UAE launches programme to empower Emirati youth address water challenges
H.H. Sheikh Mohammed pays tribute to UAE President in new book
Falcon sets world auction record at AED2.1 million in Abu Dhabi
UAE expresses solidarity with Greece over death of two pilots in plane crash
